Myocardial ischemia and infarction: Growth of ideas

Cardiovascular Research

Volumn 51, Issue 1, 2001, Pages 13-20

  Bing, Richard J ^a  

^a HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

Author keywords

Angiogenesis; Coronary disease; Infarction; Macrophages; Prostaglandins

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID 3 (NITROXYMETHYL)PHENYL ESTER; CELECOXIB; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYGEN; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE; PROSTANOID; THROMBOXANE;

ANGIOGENESIS; CARCINOMA; COMPARATIVE STUDY; DRUG EFFECT; ENZYME ACTIVATION; GLUCOSE UTILIZATION; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; INFLAMMATION; MEDIATOR RELEASE; METABOLITE; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; COLONIC NEOPLASMS; CYCLOOXYGENASE INHIBITORS; ENDOTHELIAL GROWTH FACTORS; EPOPROSTENOL; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; LYMPHOKINES; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; THROMBOXANE A2; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034995147     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(01)00250-4     Document Type: Review

References (67)

1. Metabolism of the heart
2. Metabolism of the human heart. I. Carbohydrate metabolism
3. Metabolism of the human heart. II Studies on fat, ketone, and amino acid metabolism
4. Enzymatic, metabolic, circulatory and pathologic studies in myocardial infarction
5. The metabolism of the cardiac muscle
6. Ueber die Sauerstoffatmung des isolierten Säugetierherzens
7. Ueber die Speisung des Froschherzen
8. Effect of coronary blood flow on glycolytic flux and intracellular pH in isolated rat hearts
9. Glucose and the metabolism of ischaemic myocardium
10. Proof that glucose-insulin-potassium provides metabolic protection of ischaemic myocardium?
11. Metabolic aspects of programmed cell survival and cell death in the heart
12. Effects of an intravenous infusion of a potassium-insulin-glucose solution on the electrocardiographic signs of myocardial infarction
13. Glucose-insulin-potassium in acute myocardial infarction. The time has come for a large, prospective trial
14. 14C] deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure and normal values in the conscious and anesthetized albino rat
15. 18F-labeled fluorodeoxyglucose and N-13 ammonia
16. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy
17. Effects of glucose and fatty acids on myocardial ischemia and arrhythmias
18. Cardiac fatty acid uptake and transport in health and disease
19. Long-term effects of fatty acids on cell viability and gene expression of neonatal cardiac myocytes
20. Metabolism - The lost child of cardiology
21. Infarct scar: A dynamic tissue
22. Release of prostacyclin, endothelium-derived relaxing factor and endothelin by freshly harvested cells attached to microcarrier beads
23. Inducible nitric oxide synthase activity in myocardium after myocardial infarction in rabbit
24. Production of oxidative products of nitric oxide in infarcted human heart
25. Expression of nitric oxide synthase isoforms after myocardial infarction in humans
26. New look at myocardial infarction: Toward a better aspirin
27. Enhancement of nitrate biosynthesis by Escherichia coli lipopolysaccharide
28. Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide
29. Macrophage cytotoxicity: Role for l-arginine deiminase and imino nitrogen oxidation to nitrite
30. Macrophage oxidation of l-arginine to nitrite and nitrate: Nitric oxide is an intermediate
31. Nitric oxide activates cyclooxygenase enzymes
32. Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase
33. Towards a better aspirin
34. Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs
35. Production of prostanoids and nitric oxide by infarcted heart in situ and the effect of aspirin
36. The effect of aspirin and two nitric oxide donors on the infarcted heart in situ
37. Effect of cyclooxygenase-2 inhibitor (celecoxib) on the infarcted heart in situ
38. What is the evidence that tumors are angiogenesis dependent?
39. Angiogenesis and the heart: Therapeutic implications
40. Gene therapy with angiogenic factors: A new potential approach to the treatment of ischemic diseases
41. Angiogenesis by gene therapy: A new horizon for myocardial revascularization?
42. Induction of neoangiogenesis in ischemic myocardium by human growth factors
43. VEGF gene delivery to myocardium: Deleterious effects of unregulated expression
44. VEGF gene therapy: Stimulating angiogenesis or angioma-genesis
45. Angiogenesis is coming of age
46. Molecular mechanisms of coronary collateral vessel growth
47. Regulators of angiogenesis
48. PR39, a peptide regulator of angiogenesis
49. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma
50. Combinatorial chemoprevention of intestinal neoplasia
51. Combinations for cancer prevention
52. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors
53. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer
54. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
55. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
56. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2
57. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
58. Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer
59. The relationship between cyclooxygenase-2 expression and colorectal cancer
60. Aspirin use and potential mechanisms for colorectal cancer prevention
61. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis
62. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer
63. Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation
64. Nitric oxide synthase expression and nitric oxide production in human colon carcinoma tissue
65. The role of nitric oxide (NO) in the carcinogenic process
66. Role of nitric oxide in the angiogenic response in vitro to basic fibroblast growth factor